Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
News|Articles|June 9, 2026

Can FAPI PET Enhance Pre-Op Evaluation of Peritoneal Carcinomatosis?

Author(s)Jeff Hall

Preoperative use of (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent intraclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT (FDG PET), according to new research presented at the SNMMI conference.

Emerging research suggests that (68Ga)Ga-FAPI-46 PET/CT may provide improved pre-operative assessment of patients with peritoneal carcinomatosis.

For the study, recently presented at the SNMMI conference, researchers compared (68Ga)Ga-FAPI-46 PET/CT to MRI and (18F)FDG PET/CT for preoperative evaluation of 61 patients with peritoneal carcinomatosis.

The study authors found that (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent interclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT.

Additionally, in a sub-analysis of patients who had chemotherapy in the previous three months, the researchers noted a 75 percent ICC for (68Ga)Ga-FAPI-46 PET/CT in contrast to 65 percent for MRI and 46 percent for (18F)FDG PET/CT.

“(68Ga)Ga-FAPI-46 PET/CT demonstrated the strongest agreement with surgico-pathological PCI and maintained good agreement after recent chemotherapy,” noted lead study author Ayca Arcay Ozturk, MD, a doctoral research fellow at Institut Jules Bordet in Brussels, Belgium, and colleagues.

(Editor’s note: For additional coverage from the SNMMI conference, click here.)

The researchers noted that (68Ga)Ga-FAPI-46 PET/CT demonstrated the highest segment-level sensitivity (77.6 percent) in comparison to MRI (67 percent) and (18F)FDG PET/CT (47.5 percent), but also had the lowest segment-level specificity (71.2 percent vs. 84.4 percent for MRI and 91.8 percent for (18F)FDG PET/CT).

The study authors added that (68Ga)Ga-FAPI-46 PET/CT offered a significantly higher SUVmax (13 vs. 6.15) and total lesion uptake (193.05 vs. 29.40) than (18F)FDG PET/CT.

“((68Ga)Ga-FAPI-46 PET/CT showed higher detectability than MRI and (18F)FDG PET/CT, albeit at the expense of lower specificity. These findings support (68Ga)Ga-FAPI-46 PET/CT as a promising modality for preoperative PC mapping,” maintained Ozturk and colleagues.

(Editor’s note: For related content, see “Image IQ Quiz: 56-Year-Old Man with Weight Loss and Gradual Abdominal Distention,” “New Meta-Analysis Assesses Impact of 68Ga-FAPI PET CT/MRI for Ovarian Cancer” and “MRI-Based Deep Learning for Lymph Node Metastasis Detection in Colorectal Cancer: What a New Meta-Analysis Reveals.”)

Reference

  1. Ozturk AA, Deleu AL, Poenaru R, et al. Preoperative assessment of peritoneal carcinomatosis with (68Ga)Ga-FAPI-46 PET/CT. Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), May 30-June 2, 2026, Los Angeles. Available at: https://jnm.snmjournals.org/content/67/supplement_1/261990 .


Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.